Edwards Lifesciences Corp
EW- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001099800
In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 10 sales; 1,345 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Edwards Lifesciences Corp as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,289
- +48 vs. Q4 2023
- Shares held
- 490.9M
- +8.02M (+1.7%) vs. Q4 2023
- Total value
- $46.8B
- +$9.91B (+26.9%) vs. Q4 2023
- New holders
- 157
- 437 more added
- Sold out
- 109
- 468 more reduced
19 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1,345 | $47.2B |
| Q1 2026 | 1,297 | $40.5B |
| Q4 2025 | 1,320 | $43.1B |
| Q3 2025 | 1,257 | $38.3B |
| Q2 2025 | 1,262 | $39.3B |
| Q1 2025 | 1,210 | $36.6B |
| Q4 2024 | 1,230 | $37.2B |
| Q3 2024 | 1,203 | $31.9B |
| Q2 2024 | 1,308 | $45.7B |
| Q1 2024 | 1,289 | $46.8B |
| Q4 2023 | 1,260 | $36.9B |
| Q3 2023 | 1,230 | $34.4B |
| Q2 2023 | 1,289 | $46.8B |
| Q1 2023 | 1,260 | $41.2B |
| Q4 2022 | 1,239 | $37.9B |
| Q3 2022 | 1,257 | $42.1B |
| Q2 2022 | 1,280 | $48.5B |
| Q1 2022 | 1,321 | $59.8B |
| Q4 2021 | 1,329 | $66.9B |
| Q3 2021 | 1,235 | $58.2B |
| Q2 2021 | 1,198 | $53.0B |
| Q1 2021 | 1,149 | $42.6B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Edwards Lifesciences Corp; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Columbia Trust Co 01012016 | – | – | – | – | Not filed |
| Wade G W & Inc | – | – | – | – | Not filed |
| Financial Advisors Network, Inc. | – | – | – | – | Not filed |
| Sawtooth Solutions, LLC | – | – | – | – | Not filed |
| M&G Investment Management Ltd | – | – | – | – | Not filed |
| Telemus Capital, LLC | – | – | – | – | Not filed |
| Bartlett & Co. LLC | – | – | – | – | Not filed |
| Lee Danner & Bass Inc | – | – | – | – | Not filed |
| Platform Technology Partners | – | – | – | – | Not filed |
| Sonen Capital LLC | – | – | – | – | Not filed |
| AtonRa Partners | – | – | – | – | Not filed |
| Focus Financial Network Inc | – | – | – | – | Not filed |
| Desjardins Global Asset Management Inc. | – | – | – | – | Not filed |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |
| Spartan Planning & Wealth Management | – | – | – | – | Not filed |
| Strategic Investment Solutions, Inc. | – | – | – | – | Not filed |